Clinical Performance Comparison of Several Different Contact Lenses
NCT ID: NCT00912028
Last Updated: 2018-06-19
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
71 participants
INTERVENTIONAL
2009-05-01
2010-02-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Clinical Performance Comparison of Two Contact Lenses
NCT00975585
Comparison of Two Marketed Lenses in a Controlled Environment
NCT02212301
Clinical Evaluation of Two New Silicone Hydrogel Multifocal Products
NCT00909792
Comparison of a Daily Disposable Multifocal Contact Lens to a Marketed Product
NCT05101252
Performance Comparison Between Comfilcon A and Senofilcon C Lenses
NCT02920957
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
senofilcon A
contact lens
senofilcon A
contact lens
lotrafilcon B
contact lens
lotrafilcon B
contact lens
balafilcon A
contact lens
balafilcon A
contact lens
methafilcon A
contact lens
methafilcon A
contact lens
vifilcon A
contact lens
vifilcon A
contact lens
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
senofilcon A
contact lens
lotrafilcon B
contact lens
balafilcon A
contact lens
methafilcon A
contact lens
vifilcon A
contact lens
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* be existing soft contact lens wearers of the study control lenses
* require a distance visual correction in both eyes
* have a contact lens spherical distance requirement between -1.00 diopters (D) and -8.00D in both eyes
* have astigmatism less than or equal to 1.00D in both eyes
* be able to wear lenses available for this study
* be corrected to a visual acuity of 6/9 (20/30) or better in each eye
* have normal eyes with no evidence of abnormality or disease
Exclusion Criteria
* monovision corrected
* worn lenses extended wear in the last 3 months.
* require concurrent ocular medication
* grade 3 or 4 abnormalities
* grade 3 corneal staining in more than two regions
* anterior ocular surgery
* any other ocular surgery or injury within 8 weeks prior to study enrollment
* abnormal lachrymal secretions
* pre-existing ocular irritation that would preclude contact lens fitting
* corneal irregularities
* Polymethyl methacrylate (PMMA) or Rigid Gas Permeable (RGP) lens wear in past 12 weeks
* any systemic illness which would preclude contact lens wear
* diabetes
* infectious or immunosuppressive disease
* pregnancy or lactating, or planning pregnancy at time or enrollment
* participating in a concurrent clinical study or within last 60 days
* allergy to the standardized study care solution
18 Years
39 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Johnson & Johnson Vision Care, Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Carlos E Leite Arieta, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Associate Professor - Ophthalmolgy, University of Campinas, Brazil
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Salvador, Estado de Bahia, Brazil
Maringá, Paraná, Brazil
Recife, Pernambuco, Brazil
Rio de Janeiro, Rio de Janeiro, Brazil
Campinas, São Paulo, Brazil
Marília, São Paulo, Brazil
Ribeirão Preto, São Paulo, Brazil
Santo André, São Paulo, Brazil
São Paulo, São Paulo, Brazil
São Paulo, São Paulo, Brazil
São Paulo, São Paulo, Brazil
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AOH--BRA-001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.